{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:33:36Z","timestamp":1795019616787,"version":"4.10.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["2021TR000310"],"award-info":[{"award-number":["2021TR000310"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["CP 26\/2020"],"award-info":[{"award-number":["CP 26\/2020"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["315786\/2020-5"],"award-info":[{"award-number":["315786\/2020-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq-PQ2"],"award-info":[{"award-number":["CNPq-PQ2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.compbiomed.2022.106347","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:19:17Z","timestamp":1669353557000},"page":"106347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing"],"prefix":"10.1016","volume":"152","author":[{"given":"Marcelo","family":"Falchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9456-9913","authenticated-orcid":false,"given":"Marina","family":"Delgobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Zancanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0153-6291","authenticated-orcid":false,"given":"Raquel Nascimento","family":"das Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Marc\u00e9li","family":"Stefanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cl\u00e1udia","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-3095","authenticated-orcid":false,"given":"Alfeu","family":"Zanotto-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2022.106347_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2022.106347_bib2","first-page":"97","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.compbiomed.2022.106347_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2017.09.009","article-title":"Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation","volume":"146","author":"Radenkovic","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","article-title":"Reactive oxygen species, antioxidants, and the mammalian thioredoxin system","volume":"31","author":"Nordberg","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.compbiomed.2022.106347_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2015.6378","article-title":"TrxR1 as a potent regulator of the Nrf2-Keap1 response system","volume":"23","author":"Cebula","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.compbiomed.2022.106347_bib6","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Arn\u00e9r","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.compbiomed.2022.106347_bib7","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1093\/nar\/20.15.3821","article-title":"Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulfide bond involving cysteine 62","volume":"20","author":"Matthews","year":"1992","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib8","first-page":"1243","article-title":"In vitro DNA binding activity of Fos\/Jun and BZLF1 but not C\/EBP is affected by redox changes","volume":"6","author":"Bannister","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiomed.2022.106347_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2021.10.020","article-title":"Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer","volume":"177","author":"Delgobo","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.compbiomed.2022.106347_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41408-019-0259-8","article-title":"Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma","volume":"9","author":"Wang","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.compbiomed.2022.106347_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2019.03.015","article-title":"Repurposing of auranofin: thioredoxin reductase remains a primary target of the drug","volume":"162","author":"Zhang","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.compbiomed.2022.106347_bib12","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.30467","article-title":"Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.compbiomed.2022.106347_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/med.21872","article-title":"Upgrade of an old drug: auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness","volume":"42","author":"Gamberi","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.compbiomed.2022.106347_bib14","first-page":"1057","article-title":"Menin-MLL inhibitors induce ferroptosis and enhance the anti-proliferative activity of auranofin in several types of cancer cells","volume":"57","author":"Kato","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.32410","article-title":"Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer","volume":"146","author":"Raninga","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiomed.2022.106347_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.sopen.2019.05.004","article-title":"Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models","volume":"1","author":"Rios Perez","year":"2019","journal-title":"Surg. Open Sci."},{"key":"10.1016\/j.compbiomed.2022.106347_bib17","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.18632\/oncotarget.23663","article-title":"Developing a genetic signature to predict drug response in ovarian cancer","volume":"9","author":"Hyter","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2022.106347_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/0008-5472.CAN-18-1938","article-title":"Inhibition of thioredoxin\/thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis","volume":"79","author":"Yan","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib19","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1158\/0008-5472.CAN-13-0712","article-title":"KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer","volume":"73","author":"Dai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110054","article-title":"Protein kinase C(\u03b9) and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities","volume":"37","author":"Kenchappa","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiomed.2022.106347_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41416-021-01332-x","article-title":"Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin","volume":"125","author":"Karsa","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.compbiomed.2022.106347_bib22","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/1878-0261.12476","article-title":"Targeting the thioredoxin system as a novel strategy against B-cell acute lymphoblastic leukemia","volume":"13","author":"Fidyt","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib23","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","article-title":"Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia","volume":"74","author":"Fiskus","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.redox.2016.01.007","article-title":"Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma","volume":"8","author":"Raninga","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.leukres.2010.05.011","article-title":"The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-\u03baB activity","volume":"35","author":"Nakaya","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2015-07-660365","article-title":"Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma","volume":"126","author":"Celegato","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.compbiomed.2022.106347_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.exphem.2014.10.004","article-title":"Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach","volume":"43","author":"Kiebala","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","article-title":"A comprehensive transcriptional portrait of human cancer cell lines","volume":"33","author":"Klijn","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the cancer cell line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2022.106347_bib30","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2022.106347_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106397","article-title":"RTCGAToolbox: a new tool for exporting TCGA Firehose data","volume":"9","author":"Samur","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2022.106347_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/bio.2015.0032","article-title":"A novel approach to high-quality postmortem tissue procurement: the GTEx project","volume":"13","author":"Carithers","year":"2015","journal-title":"Biopreserv. Biobanking"},{"key":"10.1016\/j.compbiomed.2022.106347_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nrc1951","article-title":"The NCI60 human tumour cell line anticancer drug screen","volume":"6","author":"Shoemaker","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2022.106347_bib36","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2022.106347_bib38","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.redox.2018.07.026","article-title":"A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations","volume":"19","author":"Levings","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib40","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib41","article-title":"OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes","volume":"7","author":"Piazza","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.106347_bib42","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib43","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1093\/nar\/gks409","article-title":"Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha","volume":"40","author":"Chorley","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib44","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","article-title":"ROCR: visualizing classifier performance in R","volume":"21","author":"Sing","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2022.106347_bib45","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib46","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","article-title":"Human non-synonymous SNPs: server and survey","volume":"30","author":"Ramensky","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib47","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.compbiomed.2022.106347_bib49","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","article-title":"MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system xc-\/glutathione Axis","volume":"81","author":"Floros","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib50","article-title":"Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer","volume":"8","author":"Oh","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiomed.2022.106347_bib51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2019.00128","article-title":"Targeting oxidative stress with auranofin or prima-1(met) to circumvent p53 or bax\/bak deficiency in myeloma cells","volume":"9","author":"Tessoulin","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/antiox9030207","article-title":"Cross-talk between bcr-abl and the thioredoxin system in chronic myeloid leukaemia: implications for CML treatment","volume":"9","author":"Clapper","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.compbiomed.2022.106347_bib53","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/bib\/bbz137","article-title":"A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies","volume":"21","author":"Yang","year":"2020","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2022.106347_bib54","doi-asserted-by":"crossref","first-page":"bbab138","DOI":"10.1093\/bib\/bbab138","article-title":"Pharmacometabonomics: data processing and statistical analysis","volume":"22","author":"Fu","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2022.106347_bib55","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/bib\/bbz049","article-title":"Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data","volume":"21","author":"Yang","year":"2020","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2022.106347_bib56","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2022.106347_bib57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2022.106347_bib58","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1073\/pnas.0806268105","article-title":"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy","volume":"105","author":"Shibata","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.compbiomed.2022.106347_bib59","first-page":"1881","article-title":"Mutations in the antioxidant KEAP1\/NRF2 pathway define an aggressive subset of NSCLC resistant to conventional treatments","volume":"14","author":"Nadal","year":"2019","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer."},{"key":"10.1016\/j.compbiomed.2022.106347_bib60","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-17-3416","article-title":"Clinical and pathological characteristics of KEAP1- and NFE2L2-mutated non-small cell lung carcinoma (NSCLC)","volume":"24","author":"Frank","year":"2018","journal-title":"Clin. Cancer Res. an Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.compbiomed.2022.106347_bib61","first-page":"1924","article-title":"Mutations in the KEAP1-NFE2L2 pathway define a molecular subset of rapidly progressing lung adenocarcinoma","volume":"14","author":"Goeman","year":"2019","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer."},{"key":"10.1016\/j.compbiomed.2022.106347_bib62","doi-asserted-by":"crossref","first-page":"69847","DOI":"10.18632\/oncotarget.19349","article-title":"NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer","volume":"8","author":"Namani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2022.106347_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-54065-6","article-title":"The balance between NRF2\/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells","volume":"9","author":"Silva","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.106347_bib64","doi-asserted-by":"crossref","first-page":"20508","DOI":"10.18632\/oncotarget.24974","article-title":"Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells","volume":"9","author":"Lisek","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2022.106347_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101949","article-title":"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire Boullosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.compbiomed.2022.106347_bib66","article-title":"Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2022.106347_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.compbiomed.2022.106347_bib68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MOH.0000000000000351","article-title":"New insights into redox homeostasis as a therapeutic target in B-cell malignancies","volume":"24","author":"Graczyk-Jarzynka","year":"2017","journal-title":"Curr. Opin. Hematol."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482522010551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482522010551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:09:22Z","timestamp":1777403362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482522010551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":68,"alternative-id":["S0010482522010551"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106347","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omics-based identification of an NRF2-related auranofin resistance signature in cancer: Insights into drug repurposing","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106347"}}